Overview
USDY and INJ rarely move in perfect sync. Today’s print ($1,882.43/$5.13) and 24h leaders (Injective) help frame which side currently carries relative strength.
Quick winners
Full comparison
| Metric | USDY | INJ |
|---|---|---|
| Price | $1,882.43 | $5.13 |
| Market Cap | $2.15B | $490.41M |
| FDV | — | — |
| Volume 24h | $1.90M | $2.59M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 40.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | USDY | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.10% | +3.91% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | USDY | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight bearish conditions on USDY and neutral on INJ. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | USDY | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
USDY
Injective
Pros and cons
Pros of USDY
- USDY often anchors narratives that attract sustained media and analyst coverage.
- Market-cap scale on USDY may dampen some idiosyncratic shocks versus smaller peers.
- Higher ranking for USDY can translate into tighter spreads on major venues.
Cons of USDY
- Indicator stacks on USDY may stay stretched longer than expected in strong trends.
- Crowded positioning around USDY sometimes amplifies squeeze or flush risk.
- Large-cap status for USDY can mean slower percentage upside versus high-beta alternatives.
Pros of Injective
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Relative underperformance versus USDY can persist through entire market regimes.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Smaller book depth versus large caps can increase slippage for Injective.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
This AI-assisted summary starts from live PEPS fields. USDY holds market-cap $2.15B and rank #40; Injective shows $490.41M and #99. Where liquidity and flow matter, watch Injective. Where durability matters, watch USDY. AI composite scores (58.20/48.70) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, USDY or Injective?
“Better” depends on horizon and risk. USDY leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, USDY or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both USDY and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.